Pharma & biotech research reports

A-Shares · 3 reports · full download after login, by plan or points

• Healthcare services, Pharma & biotech, Huada Gene 300676 Fundamental Data Research and Analysis Report.

  China’s key macro indicators for total social financing (TSF) and credit show that the outstanding TSF increased by 7.20% year-on-year this period, down 18.18% from the same period last year, and down 2.70% month-on-month. China’s key macro liquidity indicator, DR007, stood at 1.44% this period, up 0.14% year-on-year and 1.52% month-on-month. This period, the Shanghai Composite Index closed at 3,911.87 points, with a volatile performance. This period, the Shenzhen Component Index closed at 13,640.87 points, with a volatile performance. Huada Gene's current price is 39.70 yuan, the trend of weekly K-line MA10 in the medium and long term is rising, and the current structure of weekly K-line is rising. Recently, the 10-day moving average (MA10) of the daily price K-line has been fluctuating, and the current daily K-line pattern is also volatile. Trading volume has increased, and market activity has picked up.

  Healthcare services · 2026/9/19

• Biologics, Pharma & biotech, 100g bio -688276 fundamental data research and analysis report.

  China’s key macro indicators for total social financing (TSF) and credit show that the outstanding TSF increased by 7.20% year-on-year this period, down 18.18% from the same period last year, and down 2.70% month-on-month. China’s key macro liquidity indicator, DR007, stood at 1.44% this period, up 0.14% year-on-year and 1.52% month-on-month. This period, the Shanghai Composite Index closed at 3,911.87 points, with a volatile performance. This period, the Shenzhen Component Index closed at 13,640.87 points, with a volatile performance. The current price of 100 grams of biology is 16.80 yuan, the trend of weekly K-line MA10 in the medium and long term is rising, and the current structural box of weekly K-line is shaking. Recently, the 10-day moving average (MA10) of the daily price K-line has been fluctuating, and the current daily K-line pattern is also volatile. Trading volume has increased, and market activity has picked up.

  Biologics · 2026/9/19

• Chemical pharma Chemical pharma Pharma & biotech Fuxiang shares 300497 fundamental data research analysis report.

  China’s key macro indicators for total social financing (TSF) and credit show that the outstanding TSF increased by 7.20% year-on-year this period, down 18.18% from the same period last year, and down 2.70% month-on-month. China’s key macro liquidity indicator, DR007, stood at 1.42% this period, down 1.00% year-on-year and up 0.37% month-on-month. This period, the Shanghai Composite Index closed at 3,891.60 points, showing a downward trend. This period, the Shenzhen Component Index closed at 13,454.74 points, showing a downward trend. The current price of Fuxiang shares is 22.05 yuan, the trend of weekly K-line MA10 in the medium and long term is rising, and the current structure of weekly K-line is rising. Recently, the 10-day moving average (MA10) of the daily price chart is trending upward, and the current daily candlestick pattern is also bullish. Trading volume has increased, and market activity has picked up.

  Chemical pharma · 2026/9/17